Literature DB >> 24390218

A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.

Jasper Wouters1, Marguerite Stas2, Olivier Govaere1, Kathleen Barrette3, Aleksandra Dudek4, Hugo Vankelecom5, Lauren E Haydu6, John F Thompson7, Richard A Scolyer8, Joost J van den Oord1.   

Abstract

In many human cancers, the epithelial-to-mesenchymal transition has an important role in the induction of cancer stem-like cells, and hence, in the causation of intratumoral heterogeneity. This process, also referred to as mesenchymal mimicry, is, however, only poorly understood in melanoma and histological correlation is still lacking. In an immunohistochemical analysis of a large prospective series of 220 primary and metastatic melanomas for the well-known epithelial-to-mesenchymal transition marker FN1, we observed melanoma cells with high FN1 expression in metastases with ischemic necrosis, but rarely or not at all in samples lacking evidence of hypoxia. In a blinded, retrospective series of 82 melanoma metastases with 10-year follow-up, the presence of clusters of these FN1(high) melanoma cells correlated significantly with shortened melanoma-specific survival, highlighting the prognostic value of their presence. We describe in detail the unique light- and electron-microscopic features of these FN1(high) melanoma cells, enabling their identification in routinely hematoxylin-and-eosin-stained sections. In addition, by laser microdissection and subsequent gene expression analysis and immunohistochemistry, we highlight their distinctive, molecular phenotype that includes expression of various markers of the epithelial-to-mesenchymal transition (eg, ZEB1) and of melanoma stem-like cells (eg, NGFR), and lack of immunoreactivity for the melanocytic marker MITF. This phenotype could be reproduced in vitro by culturing melanoma cells under hypoxic conditions. Functionally, the hypoxic microenvironment was shown to induce a more migratory and invasive cell type. In conclusion, we identified a novel clinically relevant FN1(high)MITF(low) cell type in melanoma associated with ischemic necrosis, and propose that these cells reside at the crossroad of the epithelial-to-mesenchymal transition and stem-like cell induction, plausibly triggered by the hypoxic environment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390218     DOI: 10.1038/modpathol.2013.228

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

Review 1.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

Review 2.  Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.

Authors:  Niels Vandamme; Geert Berx
Journal:  Front Oncol       Date:  2014-12-09       Impact factor: 6.244

3.  Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.

Authors:  Kelly E Regan-Fendt; Jielin Xu; Mallory DiVincenzo; Megan C Duggan; Reena Shakya; Ryejung Na; William E Carson; Philip R O Payne; Fuhai Li
Journal:  NPJ Syst Biol Appl       Date:  2019-02-26

Review 4.  Laser Capture Microdissection in the Spatial Analysis of Epigenetic Modifications in Skin: A Comprehensive Review.

Authors:  Theja Bhamidipati; Mithun Sinha; Chandan K Sen; Kanhaiya Singh
Journal:  Oxid Med Cell Longev       Date:  2022-02-09       Impact factor: 6.543

5.  Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.

Authors:  Jasper Wouters; Zeynep Kalender-Atak; Liesbeth Minnoye; Katina I Spanier; Maxime De Waegeneer; Carmen Bravo González-Blas; David Mauduit; Kristofer Davie; Gert Hulselmans; Ahmad Najem; Michael Dewaele; Dennis Pedri; Florian Rambow; Samira Makhzami; Valerie Christiaens; Frederik Ceyssens; Ghanem Ghanem; Jean-Christophe Marine; Suresh Poovathingal; Stein Aerts
Journal:  Nat Cell Biol       Date:  2020-08-03       Impact factor: 28.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.